ID   MS428
AC   CVCL_9835
DR   EFO; EFO_0002837
DR   GEO; GSM49616
DR   Wikidata; Q54906805
RX   PubMed=15920167;
RX   PubMed=19853261;
CC   From: Fletcher, Jonathan A.; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School; Boston; USA.
CC   Omics: Transcriptome analysis by microarray.
DI   NCIt; C45663; Pleural sarcomatoid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 16
//
RX   PubMed=15920167; DOI=10.1016/S0002-9440(10)62492-3; PMCID=PMC1363736;
RA   Gordon G.J., Rockwell G.N., Jensen R.V., Rheinwald J.G.,
RA   Glickman J.N., Aronson J.P., Pottorf B.J., Nitz M.D., Richards W.G.,
RA   Sugarbaker D.J., Bueno R.;
RT   "Identification of novel candidate oncogenes and tumor suppressors in
RT   malignant pleural mesothelioma using large-scale transcriptional
RT   profiling.";
RL   Am. J. Pathol. 166:1827-1840(2005).
//
RX   PubMed=19853261; DOI=10.1016/j.jtcvs.2009.06.027;
RA   Hartman M.-L., Esposito J.M., Yeap B.Y., Sugarbaker D.J.;
RT   "Combined treatment with cisplatin and sirolimus to enhance cell death
RT   in human mesothelioma.";
RL   J. Thorac. Cardiovasc. Surg. 139:1233-1240(2010).
//